申请人:GILEAD CALISTOGA LLC
公开号:US20140235643A1
公开(公告)日:2014-08-21
The invention provides methods that relate to a novel therapeutic strategy for the treatment of cancer and inflammatory diseases. In particular, the method comprises administration of a compound of Formula I, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising such compound admixed with at least one pharmaceutically acceptable excipient.
该发明提供了一种与治疗癌症和炎症性疾病的新型治疗策略相关的方法。具体而言,该方法包括给予I式化合物或其药学上可接受的盐,或包含该化合物与至少一种药学上可接受的赋形剂混合的制剂的给药。